Vazyme Biotech

📍 Nanjing, China🗓 Founded 2012👥 155 employees💰 Last funded Apr 2020
Biotechnology Research🌐 vazymebiotech.com
Website LinkedIn
Since the establishment in 2012, Vazyme has been dedicated to our mission "Science and Technology Make a Healthier Life" to focus on technology innovation and continuously expand the application fields of core technologies in life science. Currently, we have a portfolio of over 200 kinds of genetic engineering recombinases, more than 1,000 kinds of high-performance antigens, monoclonal antibodies and other key raw materials, in addition to over 600 finished products. As a R&D based company, we have been holding ourselves to the highest standards of ethics, accountability and professionalism. Our global research and development operations make sure we could provide quality products, solutions, and services locally to our customers, and more importantly, to do as much as it can to meet the unmet customers’ needs. For now, we are present in more than 60 countries and regions worldwide to get close to local customers.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2012
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Taiwan
1
Frequently asked questions
Who invested in Vazyme Biotech?
Vazyme Biotech has 1 investors on record on gritt.io and 1 late-stage investors.
When did Vazyme Biotech last raise funding?
The most recent investment in Vazyme Biotech recorded on gritt.io was in April 2020.
When was Vazyme Biotech founded?
Vazyme Biotech was founded in 2012.
What industry is Vazyme Biotech in?
Vazyme Biotech operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Vazyme Biotech based?
Vazyme Biotech is headquartered in Nanjing, China.